Hyperuricemia and cardiovascular risk

被引：42

作者：

Grassi D. ^{[1
]}

Desideri G. ^{[1
]}

Di Giacomantonio A.V. ^{[1
]}

Di Giosia P. ^{[1
]}

Ferri C. ^{[1
]}

机构：

[1] Department of Life, Health and Environmental Sciences, University of L’Aquila, Viale S Salvatore, Delta 6 Medicina, Coppito L’Aquila

来源：

High Blood Pressure & Cardiovascular Prevention | 2014年 / 21卷 / 4期

关键词：

Cardiovascular risk; Hypertension; Metabolic risk; Uric acid;

D O I：

10.1007/s40292-014-0046-3

中图分类号：

学科分类号：

摘要：

There is an increasing prevalence of gout and hyperuricemia worldwide. Gout confers a significant individual and social burden and is increasingly recognized as a prevalent chronic disease state requiring appropriate long-term management. Gout and hyperuricemia appear to be independent risk factors for incident hypertension, renal disease and cardiovascular disease. Multiple epidemiologic studies confirm an association between hyperuricemia and “cardiometabolic disease”. We review the evidence stating the relationship between hyperuricemia and the development of comorbid conditions contributing to cardiovascular risk and disease. © 2014, Springer International Publishing Switzerland.

引用

页码：235 / 242

页数：7

共 37 条

[1]

Richette P., Gout B.T., Lancet, 375, 9711, pp. 318-328, (2010)

[2]

Choi H.K., Mount D.B., Reginato A.M., Pathogenesis of gout, Ann Intern Med, 143, pp. 499-516, (2005)

[3]

Johnson R.J., Rideout B.A., Uric acid and diet-insights into the epidemic of cardiovascular disease, N Engl J Med, 350, pp. 1071-1073, (2004)

[4]

Edwards N.L., The role of hyperuricemia and gout in kidney and cardiovascular disease, Cleve Clin J Med, 75, pp. S13-S16, (2008)

[5]

Gustafsson D., Unwin R., The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality, BMC Nephrol, 14, (2013)

[6]

Wortmann R.L., Gout and hyperuricemia, Curr Opin Rheumatol, 14, pp. 281-286, (2002)

[7]

Saag K.G., Mikuls T.R., Recent advances in the epidemiology of gout, Curr Rheumatol Rep, 7, pp. 235-241, (2005)

[8]

Grassi D., Ferri L., Desideri G., Di Giosia P., Cheli P., Del Pinto R., Properzi G., Ferri C., Chronic hyperuricemia, uric acid deposit and cardiovascular risk, Curr Pharm Des, 19, 13, pp. 2432-2438, (2013)

[9]

Johnson R.J., Kang D.H., Feig D., Kivlighn S., Kanellis J., Watanabe S., Tuttle K.R., Rodriguez-Iturbe B., Herrera-Acosta J., Mazzali M., Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?, Hypertension., 41, pp. 1183-1190, (2003)

[10]

Yoo T.W., Sung K.C., Shin H.S., Et al., Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome, Circ J, 69, pp. 928-933, (2005)

← 1 2 3 4 →